Article Versions Notes

Slavc I, Mayr L, Stepien N, Gojo J, Aliotti Lippolis M, Azizi AA, Chocholous M, Baumgartner A, Hedrich CS, Holm S, et al. Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach. Cancers. 2022; 14(20):5128. https://doi.org/10.3390/cancers14205128

Slavc, Irene, Lisa Mayr, Natalia Stepien, Johannes Gojo, Maria Aliotti Lippolis, Amedeo A. Azizi, Monika Chocholous, Alicia Baumgartner, Cora S. Hedrich, Stefan Holm, and et al. 2022. "Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach" Cancers 14, no. 20: 5128. https://doi.org/10.3390/cancers14205128

Slavc, I., Mayr, L., Stepien, N., Gojo, J., Aliotti Lippolis, M., Azizi, A. A., Chocholous, M., Baumgartner, A., Hedrich, C. S., Holm, S., Sehested, A., Leblond, P., Dieckmann, K., Haberler, C., Czech, T., Kool, M., & Peyrl, A. (2022). Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach. Cancers, 14(20), 5128. https://doi.org/10.3390/cancers14205128